2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one

C101H108ClN15O8 — CID 162183291

IUPAC2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one
SMILESCN1C(=O)C(c2cccc(-c3cccc(Cl)c3)c2)(C2CCCC2)N=C1N.COC[C@H]1CCCN1C(=O)c1cncc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)c1.COc1cccc(-c2cccc(C3(c4ccccc4)N=C(N)N(C)C3=O)c2)c1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1CC1CCN(C(=O)C2CCCCCC2)CC1
InChIInChI=1S/C29H36N4O2.C28H29N5O3.C23H21N3O2.C21H22ClN3O/c30-28-31-29(24-13-7-3-8-14-24,25-15-9-4-10-16-25)27(35)33(28)21-22-17-19-32(20-18-22)26(34)23-11-5-1-2-6-12-23;1-36-19-24-13-8-14-32(24)25(34)21-15-20(16-30-17-21)18-33-26(35)28(31-27(33)29,22-9-4-2-5-10-22)23-11-6-3-7-12-23;1-26-21(27)23(25-22(26)24,18-10-4-3-5-11-18)19-12-6-8-16(14-19)17-9-7-13-20(15-17)28-2;1-25-19(26)21(24-20(25)23,16-8-2-3-9-16)17-10-4-6-14(12-17)15-7-5-11-18(22)13-15/h3-4,7-10,13-16,22-23H,1-2,5-6,11-12,17-21H2,(H2,30,31);2-7,9-12,15-17,24H,8,13-14,18-19H2,1H3,(H2,29,31);3-15H,1-2H3,(H2,24,25);4-7,10-13,16H,2-3,8-9H2,1H3,(H2,23,24)/t;24-;;/m.1../s1
InChIKeyZPICXSBYQKXZHM-FSWRCWGUSA-N
MW1695.52 g/mol
LogP14.80
Rot. Bonds19

About 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one

2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one (PubChem CID 162183291) has the molecular formula C101H108ClN15O8 and a molecular weight of 1695.52 g/mol. Its IUPAC name is 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one.

Molecular Properties

Compound Name2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one
PubChem CID162183291
Molecular FormulaC101H108ClN15O8
Molecular Weight1695.52 g/mol
Exact Mass1693.82
IUPAC Name2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one
SMILESCN1C(=O)C(c2cccc(-c3cccc(Cl)c3)c2)(C2CCCC2)N=C1N.COC[C@H]1CCCN1C(=O)c1cncc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)c1.COc1cccc(-c2cccc(C3(c4ccccc4)N=C(N)N(C)C3=O)c2)c1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1CC1CCN(C(=O)C2CCCCCC2)CC1
InChIInChI=1S/C29H36N4O2.C28H29N5O3.C23H21N3O2.C21H22ClN3O/c30-28-31-29(24-13-7-3-8-14-24,25-15-9-4-10-16-25)27(35)33(28)21-22-17-19-32(20-18-22)26(34)23-11-5-1-2-6-12-23;1-36-19-24-13-8-14-32(24)25(34)21-15-20(16-30-17-21)18-33-26(35)28(31-27(33)29,22-9-4-2-5-10-22)23-11-6-3-7-12-23;1-26-21(27)23(25-22(26)24,18-10-4-3-5-11-18)19-12-6-8-16(14-19)17-9-7-13-20(15-17)28-2;1-25-19(26)21(24-20(25)23,16-8-2-3-9-16)17-10-4-6-14(12-17)15-7-5-11-18(22)13-15/h3-4,7-10,13-16,22-23H,1-2,5-6,11-12,17-21H2,(H2,30,31);2-7,9-12,15-17,24H,8,13-14,18-19H2,1H3,(H2,29,31);3-15H,1-2H3,(H2,24,25);4-7,10-13,16H,2-3,8-9H2,1H3,(H2,23,24)/t;24-;;/m.1../s1
InChIKeyZPICXSBYQKXZHM-FSWRCWGUSA-N
XLogP14.80
TPSA306.73 Ų
H-Bond Donors4
H-Bond Acceptors17
Rotatable Bonds19
Heavy Atoms125
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001695.52
LogP ≤ 514.80
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1017

Analyze 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one?
The IUPAC name of 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one (CID 162183291) is 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one.
What is the SMILES notation for 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one?
The canonical SMILES for 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one is CN1C(=O)C(c2cccc(-c3cccc(Cl)c3)c2)(C2CCCC2)N=C1N.COC[C@H]1CCCN1C(=O)c1cncc(CN2C(=O)C(c3ccccc3)(c3ccccc3)N=C2N)c1.COc1cccc(-c2cccc(C3(c4ccccc4)N=C(N)N(C)C3=O)c2)c1.NC1=NC(c2ccccc2)(c2ccccc2)C(=O)N1CC1CCN(C(=O)C2CCCCCC2)CC1.
What is the InChIKey of 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one?
The InChIKey is ZPICXSBYQKXZHM-FSWRCWGUSA-N. The full InChI is InChI=1S/C29H36N4O2.C28H29N5O3.C23H21N3O2.C21H22ClN3O/c30-28-31-29(24-13-7-3-8-14-24,25-15-9-4-10-16-25)27(35)33(28)21-22-17-19-32(20-18-22)26(34)23-11-5-1-2-6-12-23;1-36-19-24-13-8-14-32(24)25(34)21-15-20(16-30-17-21)18-33-26(35)28(31-27(33)29,22-9-4-2-5-10-22)23-11-6-3-7-12-23;1-26-21(27)23(25-22(26)24,18-10-4-3-5-11-18)19-12-6-8-16(14-19)17-9-7-13-20(15-17)28-2;1-25-19(26)21(24-20(25)23,16-8-2-3-9-16)17-10-4-6-14(12-17)15-7-5-11-18(22)13-15/h3-4,7-10,13-16,22-23H,1-2,5-6,11-12,17-21H2,(H2,30,31);2-7,9-12,15-17,24H,8,13-14,18-19H2,1H3,(H2,29,31);3-15H,1-2H3,(H2,24,25);4-7,10-13,16H,2-3,8-9H2,1H3,(H2,23,24)/t;24-;;/m.1../s1.
What are the key properties of 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one?
2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one has a molecular weight of 1695.52 g/mol, XLogP of 14.80, 19 rotatable bonds, 4 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-5-[3-(3-chlorophenyl)phenyl]-5-cyclopentyl-3-methylimidazol-4-one;2-amino-3-[[1-(cycloheptanecarbonyl)piperidin-4-yl]methyl]-5,5-diphenylimidazol-4-one;2-amino-3-[[5-[(2R)-2-(methoxymethyl)pyrrolidine-1-carbonyl]-3-pyridinyl]methyl]-5,5-diphenylimidazol-4-one;2-amino-5-[3-(3-methoxyphenyl)phenyl]-3-methyl-5-phenylimidazol-4-one is sourced from PubChem (CID 162183291), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).